首页>投融资
Altamira Therapeutics
增发
Altamira Therapeutics Ltd.成立于1998年。该公司的目标是成为一家领先的生物医药公司,专注于开发和商业化RNA递送技术。该公司认为,使用RNA疗法,无论是siRNA、mRNA还是其他类型来控制疾病相关基因的表达,前景广阔。通过利用小分子和蛋白质在其他方面“无法药效”的靶点,有望开辟治疗疑难杂症的RNA疗法的全新途径。
基本信息
-
公司全称Altamira Therapeutics Ltd
-
类型过敏、病毒感染、RNA治疗法开发商
-
产业领域医药研发/制造
-
公司人数15人以下
-
地址Clarendon House 2 Church Street Hamilton HM 11 Bermuda
-
联系电话1-441-2955950
-
邮箱ear@aurismedical.com
-
成立时间2003-04-01
投融资
-
2024-09-19增发400万美元未透露
-
2014-11-07上市未透露未透露
-
2014-08-06上市5245.2万美元未透露
相关投融资企业
收并购
硕腾公司于2012年7月在美国特拉华州成立,是全球领先的最大的动物保健药和疫苗公司之一。作为开发、制造商业化的动物保健药品和疫苗的全球领导者,公司一直致力于提供解决方案来提高动物的健康。
战略投资
Medic Life Sciences Inc是一家美国的生物技术公司,专注于开发创新的医疗设备和诊断技术。公司致力于改善患者的诊断和治疗体验,通过提供高效、便捷的医疗产品和服务,满足医疗市场的需求。其主要产品线包括医疗影像设备、诊断试剂和生物信息学工具等,通过不断的技术创新和市场拓展,为全球患者带来更好的医疗健康
收并购
Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides, biologics and biomarkers.
Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means less complications helping the rapid development of new drugs.
We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.
As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.
Visit our website at www.alderleyanalytical.com for more information.